Slimvance By GNC BodyDynamix Overview & Drug Interactions

Check For Interactions With Slimvance

Supplement: Slimvance by GNC BodyDynamix

Slimvance Label Images

This product contains

Below is a list of the 'active' ingredients listed on the supplement label for this product.

For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.

Drugs that interact with Slimvance by GNC BodyDynamix

Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.

Label Information

Supplement Facts:

Daily Value (DV) Target Group(s): Adults and children 4 or more years of age
Minimum serving Sizes:
1 Capsule(s)
Maximum serving Sizes:
1 Capsule(s)
Servings per container 60
UPC/BARCODE 048107183929

Ingredient Amount per Serving Group % DV, Adults & children 4+ years
Slimvance Patented Blend
450 mg
Proprietary Blend (Herb/Botanical) --
Moringa oleifera Leaf Extract
0 NP
Moringa
Murraya koenigii leaf extract
0 NP
Curryleaf
Curcuma longa root extract
0 NP
Turmeric
Curcuminoids
31.5 mg
Curcuminoid

Other Ingredients:
Gelatin
Microcrystalline Cellulose
Hydroxypropylcellulose
Calcium Silicate
Magnesium Stearate
Talc
Mica
Titanium Dioxide
Artificial Colors
Forms
  • FD&C Blue #1
  • FD&C Red #3
  • FD&C Yellow #5


Label Statments:


Brand IP Statement(s)
- A randomized clinical study of 140 healthy overweight people compared the use of Slimvance in conjunction with an 1800 calorie diet and walking plan to a placebo with the same diet and walking plan. Those on Slimvance lost almost 10 more pounds (-11.81 pounds versus -1.91 pounds), lost over an inch more around the hips (-1.76 inches vs. -0.48 inches), lost over an inch more around the waist (-2.12 inches versus -0.68 inches) and lost more percent body fat (-1.05% versus 0.71%) than the placebo group after 16 weeks.
- Slimvance is a trademark of PLT Health Solutions - Laila Nutraceuticals, LLC. US Patent #8,541,383 and international patents pending.
General Statements
- Use in conjunction with the diet and exercise plan available at www.slimvance.com/plan.
- Core slimming complex 6X more weight loss 3X hip & waist reduction
- 30-day supply
Precautions
- Keep out of reach of children.
- Warning: Consult your physician prior to using this product if you are pregnant, nursing, taking medication, or have a medical condition.
- Discontinue use two weeks prior to surgery.
- Do not exceed recommended dose per day.
Storage
- Store in a cool, dry place.
Formulation
- Stimulant free
- No Sugar, No Starch, No Artificial Flavors, Sodium Free, No Wheat, Gluten Free, No Corn, No Soy, No Dairy.
FDA Statement of Identity
- Dietary Supplement
General
- CODE 487500 JSG
Suggested/Recommended/Usage/Directions
- Directions: As a dietary supplement, take one capsule 30 minutes before breakfast and dinner. Do not exceed recommended dose per day.
FDA Disclaimer Statement
- These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Brand Information

See all products by this brand

Distributed by:
Name General Nutrition Corporation
City Pittsburgh
State PA
Country USA
ZipCode 15222
Phone Number 1-888-462-2548
Web Address slimvance.com

Return to the main supplement interaction checker page

Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Drug descriptions are provided by MedlinePlus.